Lynestrenol

Generic name
Lynestrenol
Brand name
ATC Code
G03DC03

Lynestrenol

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Postponement of menstruation
  • Oral
    • Menstruating girls/women, approximately ≥ 12 years
      • 5 mg/day in 1 dose. Max: 15 mg/day.
      • Should preferably be started 2 weeks before the expected menstruation. If less than 1 week: 10 mg/day in 1 to 2 doses. Until menstruation can be allowed to happen

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

PROGESTAGENEN

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Pregnen (4) derivatives
G03DA02
Estren derivatives
G03DC02
PREGNEN (4) DERIVATIVES
G03DA02

References

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
  2. Organon NV, SPC Orgametril (RVG 00278), www.cbg-meb.nl, Geraadpleegd 24 juni 2011, http://db.cbg-meb.nl/IB-teksten/h00278.pdf

Changes

Therapeutic Drug Monitoring


Overdose